TCL Archive Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction. April 21, 2006
TCL Archive Source Identified for Hepatitis A Contamination of LAK-IL-2 Trials; Six MIs Seen; Rosenberg Updates Intramural Results October 24, 1986
TCL Archive Funding Opportunity: NYC-based Research Alliance Offering $200,000 Per Year for Young Investigators October 3, 2014
TCL Archive In Brief: Fabien Calvo named chief scientific officer of Cancer Core Europe December 19, 2014